JANUS HENDERSON GROUP PLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANUS HENDERSON GROUP PLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$732,679
-12.7%
29,615
+0.0%
0.00%
-100.0%
Q2 2023$839,344
+23.3%
29,612
-0.1%
0.00%
Q1 2023$680,553
+182.3%
29,647
+245.2%
0.00%
Q4 2022$241,056
-0.8%
8,5890.0%0.00%
Q3 2022$243,000
-2.8%
8,589
+0.1%
0.00%
Q1 2022$250,000
-40.2%
8,584
-32.4%
0.00%
Q4 2021$418,000
+43.2%
12,694
+100.9%
0.00%
Q3 2021$292,000
-84.7%
6,320
-74.5%
0.00%
-100.0%
Q3 2018$1,913,000
-29.9%
24,800
-23.5%
0.00%
-50.0%
Q2 2018$2,729,000
+33.4%
32,400
+29.6%
0.00%
+100.0%
Q1 2018$2,045,000
-92.6%
25,000
-94.8%
0.00%
-94.1%
Q4 2017$27,741,000
+7.0%
485,239
+24.9%
0.02%0.0%
Q3 2017$25,935,000
+27.0%
388,536
-2.1%
0.02%
+21.4%
Q2 2017$20,423,000396,9540.01%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Eagle Health Investments LP 431,413$12,558,0003.09%
Casdin Capital, LLC 2,090,000$60,840,0002.73%
Rock Springs Capital Management LP 2,665,275$77,586,0001.95%
Bellevue Group AG 4,129,292$120,204,0001.40%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,177,374$34,273,0001.05%
Altium Capital Management LP 66,196$1,927,0000.64%
ArrowMark Colorado Holdings LLC 1,295,948$37,725,0000.33%
FARALLON CAPITAL MANAGEMENT LLC 1,333,012$38,804,0000.19%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 21,500$707,0000.16%
Virtus ETF Advisers LLC 11,541$336,0000.15%
View complete list of AGIOS PHARMACEUTICALS INC shareholders